Other

Drugmaker paying $33M over recalled nonprescription meds

Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.

Medical research

Metabolic biomarkers for preventive molecular medicine

A team of scientists from the Spanish National Cancer Research Centre, led by its director, MarĂ­a Blasco, together with Jose M. Mato, the director of the Center for Cooperative Research in Biosciences, has shown that the ...